^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Pancreasure

    Company:
    Immunovia
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    15d
    Immunovia publishes final AFFIRM study results in Journal of Clinical Oncology confirming strong diagnostic performance of PancreaSure (Immunovia Press Release)
    ''Immunovia AB...today announced that the final results from the AFFIRM clinical study have been published in the Journal of Clinical Oncology: Oncology Advances. The results show 88% sensitivity and 98% specificity for PancreaSure in late-stage pancreatic cancer patients and healthy, average-risk individuals, respectively, consistent with previously reported interim data.''
    Clinical
    |
    Pancreasure
    2ms
    Immunovia launches ASSURE registry to evaluate real-world clinical impact of PancreaSure in high-risk pancreatic cancer surveillance (Immunovia Press Release)
    ''Immunovia AB...today announced the launch of ASSURE, a post-marketing registry evaluating the real-world clinical impact of its commercially available blood-based biomarker test, PancreaSure. The study is designed to capture clinical data on how PancreaSure influences clinician decision-making in pancreatic cancer surveillance. Data generated in ASSURE will support Immunovia's reimbursement efforts and clinician adoption of the test.''
    Launch
    |
    Pancreasure